Divi's Laboratories [DIVISLAB] vs Torrent [TORNTPHARM] Detailed Stock Comparison

Divi's Laboratories

NSE
Loading...

Torrent

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Divi's Laboratories wins in 8 metrics, Torrent wins in 12 metrics, with 0 ties. Torrent appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricDivi's LaboratoriesTorrentBetter
P/E Ratio (TTM)67.5759.52Torrent
Price-to-Book Ratio10.4015.67Divi's Laboratories
Debt-to-Equity Ratio0.0342.81Divi's Laboratories
PEG Ratio2.553.00Divi's Laboratories
EV/EBITDA49.6631.99Torrent
Profit Margin (TTM)23.89%16.92%Divi's Laboratories
Operating Margin (TTM)25.60%26.15%Torrent
EBITDA Margin (TTM)25.60%26.15%Torrent
Return on Equity14.64%25.18%Torrent
Return on Assets (TTM)12.94%12.75%Divi's Laboratories
Free Cash Flow (TTM)$2.15B$19.73BTorrent
Dividend Yield0.91%17.47%Torrent
1-Year Return-5.14%0.83%Torrent
Price-to-Sales Ratio (TTM)16.1310.05Torrent
Enterprise Value$1,522.01B$1,215.15BDivi's Laboratories
EV/Revenue Ratio15.7710.27Torrent
Gross Profit Margin (TTM)60.33%75.26%Torrent
Revenue per Share (TTM)$363$350Divi's Laboratories
Earnings per Share (Diluted)$86.82$59.05Divi's Laboratories
Beta (Stock Volatility)0.180.13Torrent
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Divi's Laboratories vs Torrent Stock Performance Analysis

Loading Price Chart...

Divi's Laboratories
Torrent
Divi's Laboratories Stock Overview | Torrent Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Divi's Laboratories-0.67%2.26%-3.33%-15.42%10.79%-4.06%
Torrent0.32%-1.69%-2.41%5.18%9.04%3.14%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Divi's Laboratories-5.14%63.08%80.80%444.71%1,530.25%8,023.95%
Torrent0.83%121.06%28.49%130.47%1,171.87%4,673.90%

News Based Sentiment: Divi's Laboratories vs Torrent

Divi's Laboratories

News based Sentiment: MIXED

Divi's Laboratories reported strong Q3 results, but also faces mixed analyst opinions, recent underperformance, and a shift in technical trends. The company is also taking on new debt, indicating a strategic change. These factors create a complex investment narrative.

View Divi's Laboratories News Sentiment Analysis

Torrent

News based Sentiment: MIXED

Torrent Pharmaceuticals reported strong financial results for both FY24-25 and Q1 FY2025-26, but experienced notable stock price declines and technical sell signals in early October. While analyst sentiment remains largely positive, the mixed signals create a nuanced investment picture.

View Torrent News Sentiment Analysis

Performance & Financial Health Analysis: Divi's Laboratories vs Torrent

MetricDIVISLABTORNTPHARM
Market Information
Market Cap i₹1.61T₹1.21T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i455,187348,259
90 Day Avg. Volume i395,686232,734
Last Close₹5,826.50₹3,526.00
52 Week Range₹4,955.00 - ₹7,071.50₹2,886.45 - ₹3,787.90
% from 52W High-17.61%-6.91%
All-Time High₹7,071.50 (Jul 08, 2025)₹3,787.90 (Jul 30, 2025)
% from All-Time High-17.61%-6.91%
Growth Metrics
Quarterly Revenue Growth0.14%0.11%
Quarterly Earnings Growth0.27%0.20%
Financial Health
Profit Margin (TTM) i0.24%0.17%
Operating Margin (TTM) i0.26%0.26%
Return on Equity (TTM) i0.15%0.25%
Debt to Equity (MRQ) i0.0342.81
Cash & Liquidity
Book Value per Share (MRQ)₹563.87₹224.28
Cash per Share (MRQ)₹132.86₹20.33
Operating Cash Flow (TTM) i₹19.67B₹27.02B
Levered Free Cash Flow (TTM) i₹21.91B₹19.11B
Dividends
Last 12-Month Dividend Yield i0.91%17.47%
Last 12-Month Dividend i₹60.00₹552.76

Valuation & Enterprise Metrics Analysis: Divi's Laboratories vs Torrent

MetricDIVISLABTORNTPHARM
Price Ratios
P/E Ratio (TTM) i67.5759.52
Forward P/E i104.1939.44
PEG Ratio i2.553.00
Price to Sales (TTM) i16.1310.05
Price to Book (MRQ) i10.4015.67
Market Capitalization
Market Capitalization i₹1.61T₹1.21T
Enterprise Value i₹1.52T₹1.22T
Enterprise Value Metrics
Enterprise to Revenue i15.7710.27
Enterprise to EBITDA i49.6631.99
Risk & Other Metrics
Beta i0.180.13
Book Value per Share (MRQ) i₹563.87₹224.28

Financial Statements Comparison: Divi's Laboratories vs Torrent

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)DIVISLABTORNTPHARM
Revenue/Sales i₹24.10B₹31.28B
Cost of Goods Sold i₹9.56B₹7.74B
Gross Profit i₹14.54B₹23.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹6.17B₹8.31B
EBITDA i₹8.48B₹9.95B
Pre-Tax Income i₹7.33B₹7.38B
Income Tax i₹1.88B₹1.90B
Net Income (Profit) i₹5.45B₹5.48B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)DIVISLABTORNTPHARM
Cash & Equivalents i₹4.15B₹5.73B
Total Current Assets i₹100.81B₹56.23B
Total Current Liabilities i₹14.52B₹47.17B
Long-Term Debt i₹20.00M₹13.38B
Total Shareholders Equity i₹149.69B₹75.91B
Retained Earnings i₹134.00BN/A
Property, Plant & Equipment i₹3.19B₹2.99B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)DIVISLABTORNTPHARM
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDIVISLABTORNTPHARM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i455,187348,259
Average Daily Volume (90 Day) i395,686232,734
Shares Outstanding i265.47M338.45M
Float Shares i120.77M103.96M
% Held by Insiders i0.52%0.71%
% Held by Institutions i0.29%0.15%

Dividend Analysis & Yield Comparison: Divi's Laboratories vs Torrent

MetricDIVISLABTORNTPHARM
Last 12-Month Dividend i₹60.00₹552.76
Last 12-Month Dividend Yield i0.91%17.47%
3-Year Avg Annual Dividend i₹50.00₹198.92
3-Year Avg Dividend Yield i0.70%3.27%
3-Year Total Dividends i₹150.00₹596.76
Ex-Dividend DateJul 25, 2025Jun 20, 2025